KIRSKE DAVID bought XFOR
August 14, 2025 · Form 4 insider transaction
KIRSKE DAVID bought 193,254 shares of X4 Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
193,254
Price
$0.00
Total value
N/A
InsiderKIRSKE DAVID
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 14, 2025
Filing dateAugust 14, 2025
Shares owned after193,254
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units (RSUs) granted to the Reporting Person. One third of the RSUs shall vest on February 12, 2026, with the remainder vesting in equal installments in each successive quarter thereafter for a period of 12 months, subject to the Reporting Person continuing to provide services through each such date and contingent upon approval of the grant at the Issuer's 2026 Annual Meeting of Stockholders.